Brainstorm announces financial results for the third quarter of 2020 and provides a corporate update

New york, oct. 15, 2020 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the third quarter ended september 30, 2020, and provided a corporate update. "the most...
BCLI Ratings Summary
BCLI Quant Ranking